Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: A Gynecologic Oncology Group study

Gynecologic Oncology

Volumn 96, Issue 3, 2005, Pages 630-634

  Sutton, Gregory ^a,g,h   Kauderer, James ^b   Carson, Linda F ^c   Lentz, Samuel S ^d,i   Whitney, Charles W ^e   Gallion, Holly ^f,j,k  

^a St Vincent Hospitals and Health Services   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e CHRISTIANA CARE HEALTH SYSTEM   (United States)

^f UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^g Division of Gynecologic Oncology   (United States)

^h UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

ⁱ Leo W Jenkins Cancer Ctr Brody S   (United States)

^j UNIVERSITY OF PITTSBURGH   (United States)

^k Precision Therapeutics Inc   (United States)

more..

Author keywords

Carcinosarcoma; Cisplatin; Ifosfamide

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CISPLATIN; IFOSFAMIDE; MESNA;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOSARCOMA; CARDIOTOXICITY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG FEVER; DRUG INFUSION; DRUG TOLERABILITY; EXTRAVASATION; FEMALE; GASTROINTESTINAL TOXICITY; HEART INFARCTION; HUMAN; HYPERTENSION; HYSTERECTOMY; LEUKOPENIA; LUNG TOXICITY; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL RATE; THROMBOCYTOPENIA; UROGENITAL TRACT DISEASE; UTERUS CARCINOMA; WEIGHT REDUCTION;

EID: 13844272446     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.11.022     Document Type: Article

References (12)

1. K. Gerszten, C. Faul, S. Kounelis, Q. Huang, J. Kelley, and M.W. Jones The impact of adjuvant radiotherapy on carcinosarcoma of the uterus Gynecol. Oncol. 68 1998 8 13
2. N.B. Hornback, G. Omura, and F.J. Major Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma Int. J. Radiat. Oncol., Biol., Phys. 12 1986 2127 2130
3. G.A. Omura, J.A. Blessing, F.J. Major, S. Lifshitz, C. Mangan, and J. Beecham A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group study J. Clin. Oncol. 3 1985 1240 1245
4. G.P. Sutton, J.A. Blessing, N. Rosenshein, G. Photopoulos, and P.J. DiSaia Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group study) Am. J. Obstet. Gynecol. 161 1989 309 315
5. J.T. Thigpen, J.A. Blessing, J. Beecham, H. Homesley, and E. Yordan Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study J. Clin. Oncol. 9 1991 1962 1966
6. K.V. Kahanpaa, T. Wahlstrom, P. Grohn, E. Heinomen, V. Nieminen, and O. Wildholm Sarcomas of the uterus: a clinicopathologic study of 119 patients Obstet. Gynecol. 67 1986 417 424
7. E. Sartori, L. Bazzurini, A. Gadducci, F. Landom, A. Lissoni, and T. Maggino Carcinoma of the uterus: a clinicopathological multicenter CTF study Gynecol. Oncol. 67 1997 70 75
8. E.L. Podczaski, C.A. Woomert, C.W. Stevens, A. Manetta, J.E. Larson, and R.J. Zaino Management of malignant, mixed mesodermal tumors of the uterus Gynecol. Oncol. 32 1989 240 244
9. D.S. Chi, B. Mychalczak, P.E. Saigo, J. Rescigno, and C.V. Braun The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma Gynecol. Oncol. 65 1997 493 498
10. K.H. Antman Adjuvant therapy of sarcomas of soft tissue Senim. Oncol. 24 1997 556 560
11. E.V. Hannigan, R.S. Freedman, and F.N. Rutledge Adjuvant chemotherapy in early uterine sarcomas Gynecol. Oncol. 15 1983 56 64
12. T.P. Manolitsas, G.V. Wain, K.E. Williams, M. Freidlander, and N.F. Hacker Multimodality therapy for patients with clinical stage I and II malignant mixed Mullerian tumors of the uterus Cancer 91 2001 1437 1443